OncoCipherPATIENT
Educational & Guideline Reference Notice: Unranked FDA-label and national guideline option categories and recruiting clinical trials for discussion with a licensed oncologist. Protocol drug dosing and autonomous treatment prescriptions are excluded.

← Colorectal Cancer (CRC) Overview

Colorectal Cancer (CRC) — 507 Curated Clinical Trials

Registry Snapshot: 2026-10-23 · Table SHA-256: a8aebe621b7b6a9f

NCT IdentifierTitle & SponsorPhase / Status
NCT01174121Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
National Cancer Institute (NCI)
PHASE2
RECRUITING
NCT01365169Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
M.D. Anderson Cancer Center
NA
RECRUITING
NCT02000089The Cancer of the Pancreas Screening-5 CAPS5)Study
Johns Hopkins University
PHASE3
RECRUITING
NCT02172651Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
Dana-Farber Cancer Institute
EARLY_PHASE1
RECRUITING
NCT02448173A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Vaccinogen Inc
PHASE3
NOT_YET_RECRUITING
NCT02584244Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Lumicell, Inc.
PHASE1|PHASE2
RECRUITING
NCT02600949Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
M.D. Anderson Cancer Center
PHASE1
ACTIVE_NOT_RECRUITING
NCT03051464Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery
Sir Mortimer B. Davis - Jewish General Hospital
PHASE2|PHASE3
RECRUITING
NCT03093116A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Turning Point Therapeutics, Inc.
PHASE1|PHASE2
RECRUITING
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Apollomics Inc.
PHASE2
RECRUITING
NCT03190941Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
National Cancer Institute (NCI)
PHASE1|PHASE2
RECRUITING
NCT03516708Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Washington University School of Medicine
PHASE1|PHASE2
RECRUITING
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Merus B.V.
PHASE1|PHASE2
RECRUITING
NCT03539822Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
Anwaar Saeed
PHASE1|PHASE2
RECRUITING
NCT03594630Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
EARLY_PHASE1
RECRUITING
NCT03659448Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Surgimab
PHASE3
RECRUITING
NCT03692429alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
Celyad Oncology SA
PHASE1
RECRUITING
NCT03715933Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Inhibrx Biosciences, Inc
PHASE1
RECRUITING
NCT03740256Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Baylor College of Medicine
PHASE1
RECRUITING
NCT03816345Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT03823144Intravital Microscopy in Human Solid Tumors
Mayo Clinic
NA
RECRUITING
NCT03947385Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
IDEAYA Biosciences
PHASE1|PHASE2
RECRUITING
NCT03965234Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Roswell Park Cancer Institute
PHASE1|PHASE2
RECRUITING
NCT04165772Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
Memorial Sloan Kettering Cancer Center
PHASE2
RECRUITING
NCT04184973Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Colospan Ltd.
NA
RECRUITING
NCT04221893Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
University of California, San Francisco
NA
RECRUITING
NCT04222413Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT04282044Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
BioEclipse Therapeutics
PHASE1
RECRUITING
NCT04329494PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
PHASE1
RECRUITING
NCT04339374Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
Washington University School of Medicine
NA
RECRUITING
NCT04373564Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Guerbet
PHASE4
RECRUITING
NCT04421820BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Bold Therapeutics, Inc.
PHASE1|PHASE2
RECRUITING
NCT04429542Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Bicara Therapeutics
PHASE1
RECRUITING
NCT04494945Identifying and Caring for Individuals With Inherited Cancer Syndrome
OHSU Knight Cancer Institute
NA
RECRUITING
NCT04511039Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Roswell Park Cancer Institute
PHASE1
RECRUITING
NCT04585750The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PHASE1|PHASE2
RECRUITING
NCT04589468Researching the Effect of Exercise on Cancer
City of Hope Medical Center
NA
RECRUITING
NCT04643366Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
Virginia Commonwealth University
PHASE2
RECRUITING
NCT04657068A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Artios Pharma Ltd
PHASE1|PHASE2
RECRUITING
NCT04674267Resilience and Equity in Aging, Cancer, and Health (REACH)
Dana-Farber Cancer Institute
NA
RECRUITING
NCT04678648A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
PHASE1
RECRUITING
NCT04693377Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
NA
RECRUITING
NCT04701476TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Teclison Ltd.
PHASE2
RECRUITING
NCT04703101Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Jonsson Comprehensive Cancer Center
PHASE1
RECRUITING
NCT04722341Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
Cedars-Sinai Medical Center
NA
RECRUITING
NCT04751435Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Memorial Sloan Kettering Cancer Center
NA
RECRUITING
NCT04771520Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT04779554Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Prakash Pandalai
PHASE2
RECRUITING
NCT04796818An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
M.D. Anderson Cancer Center
NA
RECRUITING
NCT04808323MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
Medical College of Wisconsin
PHASE1
RECRUITING
NCT04847063Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT04851119Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
PHASE1|PHASE2
RECRUITING
NCT04895709A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
PHASE1|PHASE2
RECRUITING
NCT04899908Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Brigham and Women's Hospital
PHASE2
RECRUITING
NCT04907643Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
NA
RECRUITING
NCT04913285A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Pierre Fabre Medicament
PHASE1
RECRUITING
NCT04916990Improving Care for Rural Patients With Solid Tumors
University of Colorado, Denver
NA
RECRUITING
NCT04920032Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
University of California, Irvine
PHASE1
RECRUITING
NCT04929223A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Hoffmann-La Roche
PHASE1
RECRUITING
NCT04991948Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
Celyad Oncology SA
PHASE1
RECRUITING
NCT05005403Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
AbbVie
PHASE1
RECRUITING
NCT05024097A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
Weill Medical College of Cornell University
PHASE2
RECRUITING
NCT05053555High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
M.D. Anderson Cancer Center
NA
RECRUITING
NCT05062317ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT05064280Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT05080673Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NRG Oncology
NA
RECRUITING
NCT05086692A Beta-only IL-2 ImmunoTherapY Study
Medicenna Therapeutics, Inc.
PHASE1|PHASE2
RECRUITING
NCT05107674A Study of NX-1607 in Adults With Advanced Malignancies
Nurix Therapeutics, Inc.
PHASE1
RECRUITING
NCT05174169Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
NRG Oncology
PHASE2|PHASE3
RECRUITING
NCT05174286Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
Columbia University
NA
RECRUITING
NCT05176483Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Exelixis
PHASE1
RECRUITING
NCT05195710Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
M.D. Anderson Cancer Center
PHASE1
RECRUITING
NCT05204147Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
City of Hope Medical Center
PHASE1
RECRUITING
NCT05225428Video Education With Result Dependent dIsclosure
Dana-Farber Cancer Institute
NA
COMPLETED
NCT05239546Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
University of Iowa
PHASE2
RECRUITING
NCT05253651A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Seagen, a wholly owned subsidiary of Pfizer
PHASE3
RECRUITING
NCT05254327Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
University of Nebraska
PHASE2
RECRUITING
NCT05265169Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)
Society of Interventional Oncology
NA
RECRUITING
NCT05283330Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Orano Med Theranostics, SAS
PHASE1
RECRUITING
NCT05286814PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
National Cancer Institute (NCI)
PHASE2
RECRUITING
NCT05296681Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
Howard S. Hochster, MD
PHASE2
RECRUITING
NCT05297734Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
NA
RECRUITING
NCT05319314LYL273 for Patients With Relapsed or Refractory mCRC
Lyell Immunopharma, Inc.
PHASE1|PHASE2
RECRUITING
NCT05321134Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
University of California, Davis
NA
RECRUITING
NCT05346796Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
Indiana University
NA
RECRUITING
NCT05379595A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Janssen Research & Development, LLC
PHASE1|PHASE2
RECRUITING
NCT05379985Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Revolution Medicines, Inc.
PHASE1|PHASE2
RECRUITING
NCT05391126GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Reema A. Patel
NA
RECRUITING
NCT05411718A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT05412082SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
University of Miami
PHASE1
RECRUITING
NCT05428735The DRAGON 2 Trial
Maastricht University
NA
RECRUITING
NCT05433142Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor, Inc.
PHASE1
RECRUITING
NCT05447923Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Mayo Clinic
NA
RECRUITING
NCT05482516Evaluating Novel Therapies in ctDNA Positive GI Cancers
Georgetown University
PHASE3
ACTIVE_NOT_RECRUITING
NCT05482893Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Phanes Therapeutics
PHASE1|PHASE2
RECRUITING
NCT05489211Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
AstraZeneca
PHASE2
RECRUITING
NCT05524428Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
Massachusetts General Hospital
NA
RECRUITING
NCT05556473F-Tryptophan PET/CT in Human Cancers
Barbara Ann Karmanos Cancer Institute
PHASE1
COMPLETED
NCT05584670A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
Sanofi
PHASE1|PHASE2
RECRUITING
NCT05592626A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Marengo Therapeutics, Inc.
PHASE1|PHASE2
RECRUITING
NCT05612347Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Dartmouth-Hitchcock Medical Center
NA
RECRUITING
NCT05630794Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT05643859Impact of Dietary Fiber Supplementation on Colonic Microbiome
OHSU Knight Cancer Institute
NA
RECRUITING
NCT05649072Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
M.D. Anderson Cancer Center
NA
RECRUITING
NCT05663203A Web-Based Dyadic Intervention for Colorectal Cancer
Emory University
NA
RECRUITING
NCT05669430A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
GV20 Therapeutics
PHASE1|PHASE2
RECRUITING
NCT05672108Phase II Trial of Lung Chemoemobolization
City of Hope Medical Center
PHASE2
RECRUITING
NCT05672524A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Memorial Sloan Kettering Cancer Center
PHASE2
RECRUITING
NCT05673148Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Alliance for Clinical Trials in Oncology
PHASE2
RECRUITING
NCT05686226E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Christian Hinrichs
PHASE2
RECRUITING
NCT05691491Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
National Cancer Institute (NCI)
PHASE1|PHASE2
RECRUITING
NCT05692024COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
Massachusetts General Hospital
PHASE1|PHASE2
RECRUITING
NCT05694559Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
M.D. Anderson Cancer Center
NA
RECRUITING
NCT05705492Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
PHASE2
RECRUITING
NCT05719558A Study of ASP1002 in Adults for Treatment of Solid Tumors
Astellas Pharma Global Development, Inc.
PHASE1
RECRUITING
NCT05733000CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Northwestern University
PHASE2
RECRUITING
NCT05742178NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
NYU Langone Health
NA
RECRUITING
NCT05746897A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Hefei TG ImmunoPharma Co., Ltd.
PHASE1
RECRUITING
NCT05773144Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
AdventHealth Translational Research Institute
NA
RECRUITING
NCT05780684Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
Dartmouth-Hitchcock Medical Center
NA
RECRUITING
NCT05784688Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
TiumBio Co., Ltd.
PHASE1|PHASE2
RECRUITING
NCT05785780Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
Rutgers, The State University of New Jersey
NA
ENROLLING_BY_INVITATION
NCT05786924Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Institut de Recherches Internationales Servier
PHASE1|PHASE2
RECRUITING
NCT05789433Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
AdventHealth Translational Research Institute
NA
RECRUITING
NCT05803382Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT05806931Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Rutgers, The State University of New Jersey
PHASE2
RECRUITING
NCT05824975A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
GI Innovation, Inc.
PHASE1|PHASE2
RECRUITING
NCT05826743Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
JSR Medical Co., Ltd.
NA
RECRUITING
NCT05854498Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
University of Wisconsin, Madison
PHASE2
RECRUITING
NCT05855200Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
GlaxoSmithKline
PHASE3
RECRUITING
NCT05856981Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Sairopa B.V.
PHASE1
RECRUITING
NCT05863195Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
ECOG-ACRIN Cancer Research Group
PHASE3
RECRUITING
NCT05868226PRE-ISPY Phase I/II Oncology Platform Program
QuantumLeap Healthcare Collaborative
PHASE1|PHASE2
RECRUITING
NCT05870800Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
Baylor College of Medicine
PHASE2
RECRUITING
NCT05877599A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
AstraZeneca
PHASE1
RECRUITING
NCT05914766An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
Massachusetts General Hospital
NA
RECRUITING
NCT05919264FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
PHASE1|PHASE2
RECRUITING
NCT05936931Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
Virginia Commonwealth University
NA
NOT_YET_RECRUITING
NCT05943210The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
Weill Medical College of Cornell University
NA
RECRUITING
NCT05947838A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma
M.D. Anderson Cancer Center
NA
RECRUITING
NCT05969860At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Mayo Clinic
PHASE2
RECRUITING
NCT05984589Personalized Health Self-Management Training for Colorectal Cancer Survivors
University of Southern California
NA
RECRUITING
NCT05985954Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
M.D. Anderson Cancer Center
PHASE1
RECRUITING
NCT06004245A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Vividion Therapeutics, Inc.
PHASE1
RECRUITING
NCT06026410KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Kura Oncology, Inc.
PHASE1
RECRUITING
NCT06037954A Study of Mental Health Care in People With Cancer
Memorial Sloan Kettering Cancer Center
NA
RECRUITING
NCT06040541Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Revolution Medicines, Inc.
PHASE1
RECRUITING
NCT06047379Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
PHASE1|PHASE2
RECRUITING
NCT06051695A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
A2 Biotherapeutics Inc.
PHASE1|PHASE2
RECRUITING
NCT06055439A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Chimeric Therapeutics
PHASE1|PHASE2
ACTIVE_NOT_RECRUITING
NCT06063928Confronting Cancer as a Community
University of Southern California
NA
RECRUITING
NCT06065371Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
Henry Ford Health System
PHASE1
RECRUITING
NCT06085560Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening
Michigan State University
NA
ENROLLING_BY_INVITATION
NCT06101277Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
University of California, Davis
NA
RECRUITING
NCT06102902Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT06117241Reducing Metabolic Dysregulation in Dyads
University of South Carolina
NA
RECRUITING
NCT06128551Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Revolution Medicines, Inc.
PHASE1|PHASE2
RECRUITING
NCT06130280A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
Memorial Sloan Kettering Cancer Center
PHASE2
RECRUITING
NCT06130826Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
City of Hope Medical Center
PHASE1
ACTIVE_NOT_RECRUITING
NCT06131840A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Seagen, a wholly owned subsidiary of Pfizer
PHASE1
RECRUITING
NCT06133439Rural Indiana Screening for Colorectal Cancer
Indiana University
NA
ENROLLING_BY_INVITATION
NCT06134687Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Baylor College of Medicine
NA
RECRUITING
NCT06149481Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
National Cancer Institute (NCI)
PHASE1|PHASE2
RECRUITING
NCT06159634Traction vs. No Traction in Colonic ESD
Baylor College of Medicine
NA
RECRUITING
NCT06179160A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Incyte Corporation
PHASE1
RECRUITING
NCT06184594Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening
Icahn School of Medicine at Mount Sinai
NA
ENROLLING_BY_INVITATION
NCT06191185IMProving Adherence to Colonoscopy Through Teams and Technology
University of California, San Francisco
NA
ACTIVE_NOT_RECRUITING
NCT06202183Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
Dana-Farber Cancer Institute
NA
RECRUITING
NCT06205485Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Canadian Cancer Trials Group
PHASE3
RECRUITING
NCT06205836Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
PHASE2
RECRUITING
NCT06218914Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
AstraZeneca
PHASE1
RECRUITING
NCT06225011Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
Jonsson Comprehensive Cancer Center
PHASE1
RECRUITING
NCT06228209Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
Icahn School of Medicine at Mount Sinai
NA
RECRUITING
NCT06239194Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
PHASE1|PHASE2
RECRUITING
NCT06242470A Study of MGC026 in Participants With Advanced Solid Tumors
MacroGenics
PHASE1
RECRUITING
NCT06244771A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Frontier Medicines Corporation
PHASE1|PHASE2
RECRUITING
NCT06252649Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Amgen
PHASE3
RECRUITING
NCT06253871A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
PHASE1
RECRUITING
NCT06258525SAMe in Prevention of Oxaliplatin-associated Liver Injury
Cedars-Sinai Medical Center
PHASE2
NOT_YET_RECRUITING
NCT06263088EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
NA
RECRUITING
NCT06265285Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Mayo Clinic
PHASE2
RECRUITING
NCT06269744Proactive Outreach With FIT
NYU Langone Health
NA
ENROLLING_BY_INVITATION
NCT06270706A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
PHASE1
RECRUITING
NCT06281678A Study of IBI363 in Subjects with Advanced Solid Malignancies
Innovent Biologics (Suzhou) Co. Ltd.
PHASE2
RECRUITING
NCT0629891664Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Lantheus Medical Imaging
PHASE1|PHASE2
RECRUITING
NCT06300463Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Weill Medical College of Cornell University
PHASE2
RECRUITING
NCT06307548Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Roswell Park Cancer Institute
PHASE1|PHASE2
RECRUITING
NCT06324357Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
PHASE1|PHASE2
RECRUITING
NCT06330064A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Daiichi Sankyo
PHASE1|PHASE2
RECRUITING
NCT06336902Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
University of Southern California
PHASE1
RECRUITING
NCT06340646Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Washington University School of Medicine
NA
RECRUITING
NCT06349590Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
University of Chicago
PHASE1|PHASE2
RECRUITING
NCT06362369A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
PHASE1|PHASE2
RECRUITING
NCT06369259Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT06371768Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Duke University
NA
RECRUITING
NCT06376565Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Jonsson Comprehensive Cancer Center
NA
RECRUITING
NCT06380101Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
University of South Florida
NA
RECRUITING
NCT06384352Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
PHASE1
RECRUITING
NCT06385925A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Tyligand Pharmaceuticals (Suzhou) Limited
PHASE1|PHASE2
RECRUITING
NCT06395519A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
858 Therapeutics, Inc.
PHASE1|PHASE2
RECRUITING
NCT06400472A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Eli Lilly and Company
PHASE1
RECRUITING
NCT06401174Patient Navigation for Colorectal Cancer Screening
Medstar Health Research Institute
NA
ENROLLING_BY_INVITATION
NCT06411691KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
PHASE1
RECRUITING
NCT06412198A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
M.D. Anderson Cancer Center
PHASE1|PHASE2
RECRUITING
NCT06424522A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
Ohio State University Comprehensive Cancer Center
NA
RECRUITING
NCT06428409A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Merck Sharp & Dohme LLC
PHASE1|PHASE2
RECRUITING
NCT06440005A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Angiex, Inc.
PHASE1
RECRUITING
NCT06444815A Study of VET3-TGI in Patients With Solid Tumors
KaliVir Immunotherapeutics
PHASE1
RECRUITING
NCT06445062Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Revolution Medicines, Inc.
PHASE1|PHASE2
RECRUITING
NCT06451497This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Zumutor Biologics Inc.
PHASE1
RECRUITING
NCT06458998Getting To Implementation: Improving Cancer Screening for Veterans
University of Pittsburgh
NA
ENROLLING_BY_INVITATION
NCT06462521Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection
Indiana University
NA
ENROLLING_BY_INVITATION
NCT06496256Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Palette Life Sciences, Inc.
NA
RECRUITING
NCT06528990Telehealth Intervention for Ostomy Self-Management
City of Hope Medical Center
PHASE2
RECRUITING
NCT06529523Tislelizumab in People With Colorectal Cancer
Memorial Sloan Kettering Cancer Center
PHASE2
RECRUITING
NCT06534918Precise Oncology Interventions in Nutrition and Training (OnPoint)
University of Miami
NA
RECRUITING
NCT06542835Community Partnership for Telehealth Solutions to Convey Information and Enhance Care
University of Arizona
NA
COMPLETED
NCT06553885Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
H. Lee Moffitt Cancer Center and Research Institute
PHASE2
RECRUITING
NCT06555133Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
Brown University
PHASE2
RECRUITING
NCT06555588Engage Psychosocial Intervention for Cancer Symptoms
Duke University
NA
RECRUITING
NCT06557733An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
PHASE2
RECRUITING
NCT06559059Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
NYU Langone Health
NA
RECRUITING
NCT06562192Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Novartis Pharmaceuticals
PHASE1
RECRUITING
NCT06562543A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Takeda
PHASE4
RECRUITING
NCT06563388Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Roswell Park Cancer Institute
PHASE3
RECRUITING
NCT06565052The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
Dana-Farber Cancer Institute
NA
RECRUITING
NCT06568016A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
Jonsson Comprehensive Cancer Center
NA
RECRUITING
NCT06569368Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT06576037Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
M.D. Anderson Cancer Center
PHASE1
RECRUITING
NCT06578637Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis
Abramson Cancer Center at Penn Medicine
NA
ENROLLING_BY_INVITATION
NCT06580002Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
University of California, Irvine
PHASE2
RECRUITING
NCT06586515MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Eli Lilly and Company
PHASE1
ACTIVE_NOT_RECRUITING
NCT06589440Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
Stingray Therapeutics
PHASE2
RECRUITING
NCT06598007A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
Crossignal Therapeutics, Inc.
PHASE1|PHASE2
RECRUITING
NCT06603519Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy
University of California, San Diego
NA
ENROLLING_BY_INVITATION
NCT06605430Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
HealthPartners Institute
PHASE2
RECRUITING
NCT06607458Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Delcath Systems Inc.
PHASE2
RECRUITING
NCT06612281Evaluation of Gixam's Performance in a FIT Negative Population
Jubaan Ltd.
PHASE2
RECRUITING
NCT06617858Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT06625775Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
PHASE1
RECRUITING
NCT06634875Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Buzzard Pharmaceuticals
PHASE2
RECRUITING
NCT06637462A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
Memorial Sloan Kettering Cancer Center
NA
RECRUITING
NCT06638502Safety of HRX215 in Patients After Minor and Major Liver Resection
HepaRegeniX GmbH
PHASE1|PHASE2
RECRUITING
NCT06641310Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
University of Michigan Rogel Cancer Center
NA
RECRUITING
NCT06654037Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT06656936The PharmFIT Study
UNC Lineberger Comprehensive Cancer Center
NA
NOT_YET_RECRUITING
NCT06657144A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Coherus Oncology, Inc.
PHASE1
RECRUITING
NCT06662786A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Janssen Research & Development, LLC
PHASE3
RECRUITING
NCT06663319A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Janssen Research & Development, LLC
PHASE1
RECRUITING
NCT06666192The Ohio State University (OSU) SCREEN Community Program
Ohio State University Comprehensive Cancer Center
NA
RECRUITING
NCT06669572Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
University of Chicago
PHASE2
RECRUITING
NCT06673329Brodalumab in the Treatment of Immune-Related Adverse Events
Brian Henick, MD
PHASE1
RECRUITING
NCT06682650Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
University of Kansas Medical Center
NA
RECRUITING
NCT06682793A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
A2 Biotherapeutics Inc.
PHASE1|PHASE2
RECRUITING
NCT06695845A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Jazz Pharmaceuticals
PHASE2
RECRUITING
NCT06696768Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT06710756Lead-212 PSV359 Therapy for Patients With Solid Tumors
Perspective Therapeutics
PHASE1|PHASE2
RECRUITING
NCT06720987A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
PHASE1
RECRUITING
NCT06723236A Study of MGC028 in Participants With Advanced Solid Tumors
MacroGenics
PHASE1
RECRUITING
NCT06728072Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Virginia Commonwealth University
PHASE2
RECRUITING
NCT06731894Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
City of Hope Medical Center
PHASE2
RECRUITING
NCT06731998Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NA
RECRUITING
NCT06745895Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
H. Lee Moffitt Cancer Center and Research Institute
NA
RECRUITING
NCT06746012Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
Ohio State University Comprehensive Cancer Center
NA
RECRUITING
NCT06750094A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Janssen Research & Development, LLC
PHASE3
RECRUITING
NCT06751329A Study of DM002 in Patients With Advanced Solid Tumors
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
PHASE1|PHASE2
RECRUITING
NCT06756035CT-95 in Advanced Cancers Associated With Mesothelin Expression
Context Therapeutics Inc.
PHASE1
RECRUITING
NCT06760819A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Bayer
PHASE2
RECRUITING
NCT06764771A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Bristol-Myers Squibb
PHASE1
RECRUITING
NCT06778863A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Clasp Therapeutics, Inc.
PHASE1
RECRUITING
NCT06780787FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
City of Hope Medical Center
PHASE2
RECRUITING
NCT06789172A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Epkin
PHASE1
RECRUITING
NCT06792695A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
AstraZeneca
PHASE2
ACTIVE_NOT_RECRUITING
NCT06802172Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
Fred Hutchinson Cancer Center
NA
RECRUITING
NCT06811454Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
Case Comprehensive Cancer Center
NA
NOT_YET_RECRUITING
NCT06819228Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
PHASE1
RECRUITING
NCT06820463A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
AbbVie
PHASE2
RECRUITING
NCT06822530A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Fred Hutchinson Cancer Center
NA
RECRUITING
NCT06824064Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
Riboscience, LLC.
PHASE2
RECRUITING
NCT06833866Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
The Methodist Hospital Research Institute
PHASE1
RECRUITING
NCT06834126Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
City of Hope Medical Center
PHASE1
RECRUITING
NCT06835569A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Alterome Therapeutics, Inc.
PHASE1
RECRUITING
NCT06843434A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma
Memorial Sloan Kettering Cancer Center
PHASE2
RECRUITING
NCT06885034A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
GlaxoSmithKline
PHASE1|PHASE2
RECRUITING
NCT06885697Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Cancer Institute (NCI)
PHASE1
RECRUITING
NCT068872185-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
The Methodist Hospital Research Institute
PHASE2
RECRUITING
NCT06887673Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
EARLY_PHASE1
NOT_YET_RECRUITING
NCT06896162PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
UNC Lineberger Comprehensive Cancer Center
NA
RECRUITING
NCT06910657IDOV-Immune for Advanced Solid Tumors
ViroMissile, Inc.
PHASE1
RECRUITING
NCT06914726Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes
HealthPartners Institute
NA
ENROLLING_BY_INVITATION
NCT06917079BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
PHASE1
RECRUITING
NCT06931860Head to Head Trial of Mailed Cologuard to Mailed FIT
University of California, San Diego
NA
ENROLLING_BY_INVITATION
NCT06934538First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
Brenus Pharma
PHASE1|PHASE2
RECRUITING
NCT06937177Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Endevica Bio
PHASE2
RECRUITING
NCT06948448A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Ono Pharmaceutical Co., Ltd.
PHASE2
RECRUITING
NCT06950385Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Rapamycin Holdings Inc.
PHASE3
RECRUITING
NCT06959550Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT06973564JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Jacobio Pharmaceuticals Co., Ltd.
PHASE1|PHASE2
RECRUITING
NCT06974110Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
PHASE1
RECRUITING
NCT06983743A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Erasca, Inc.
PHASE1
RECRUITING
NCT06992258A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Criterium, Inc.
PHASE2
RECRUITING
NCT06995898The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
NA
RECRUITING
NCT06995924Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
Fred Hutchinson Cancer Center
NA
RECRUITING
NCT06997497A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Merck Sharp & Dohme LLC
PHASE3
RECRUITING
NCT07011576A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
SCRI Development Innovations, LLC
PHASE2
RECRUITING
NCT07018869Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
SWOG Cancer Research Network
PHASE3
RECRUITING
NCT07020117A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Aktis Oncology, Inc.
PHASE1
RECRUITING
NCT07020221A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
PHASE1|PHASE2
RECRUITING
NCT07023289A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
AbbVie
PHASE2
RECRUITING
NCT07030257Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Tasca Therapeutics
PHASE1|PHASE2
RECRUITING
NCT07033026An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
NGM Biopharmaceuticals, Inc
PHASE2
RECRUITING
NCT07042243The Florida ASCENT Study
University of Florida
NA
RECRUITING
NCT07042685Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
The Methodist Hospital Research Institute
PHASE2
RECRUITING
NCT07044362Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Case Comprehensive Cancer Center
NA
RECRUITING
NCT07050485Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
University of South Florida
NA
ENROLLING_BY_INVITATION
NCT07058012A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
NSABP Foundation Inc
PHASE2
RECRUITING
NCT07059884Distance-Based Exercise to Preserve Function and Prevent Disability
Alliance for Clinical Trials in Oncology
NA
RECRUITING
NCT07066657A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
ArriVent BioPharma, Inc.
PHASE1
RECRUITING
NCT07070232A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
BioNTech SE
PHASE1|PHASE2
RECRUITING
NCT07071454Preventing Early-Onset Colorectal Cancer in the VA
VA Office of Research and Development
NA
NOT_YET_RECRUITING
NCT07071961Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
M.D. Anderson Cancer Center
PHASE2
RECRUITING
NCT07079631A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
BioNTech SE
PHASE1|PHASE2
RECRUITING
NCT07082439Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma
Abramson Cancer Center at Penn Medicine
PHASE2
RECRUITING
NCT07085091A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ALX Oncology Inc.
PHASE1
RECRUITING
NCT07086833The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Purdue University
NA
RECRUITING
NCT07091032Building Connections
Massachusetts General Hospital
NA
RECRUITING
NCT07094113AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Amgen
PHASE1
RECRUITING
NCT07094204A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Astellas Pharma Inc
PHASE1
RECRUITING
NCT07095517Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
Massachusetts General Hospital
PHASE1
RECRUITING
NCT07106359Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
University of Alabama at Birmingham
NA
RECRUITING
NCT07114601A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Eli Lilly and Company
PHASE1
RECRUITING
NCT07115875Improving Rates of Diagnostic Colonoscopy in Native Americans
University of Oklahoma
NA
NOT_YET_RECRUITING
NCT07116668SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study
SafeHeal Inc
NA
ENROLLING_BY_INVITATION
NCT07125729Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
City of Hope Medical Center
NA
RECRUITING
NCT07127874A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
PHASE1
RECRUITING
NCT07128355Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
Massachusetts General Hospital
EARLY_PHASE1
RECRUITING
NCT07130903Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
PHASE2
RECRUITING
NCT07140679Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
Emory University
PHASE2
RECRUITING
NCT07141901Life Expectancy-informed Colorectal Cancer Screening
Kathryn Martinez
NA
NOT_YET_RECRUITING
NCT07143487Family Communications After Genetic Testing
Alliance for Clinical Trials in Oncology
NA
RECRUITING
NCT07145255Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
MBrace Therapeutics
PHASE1|PHASE2
RECRUITING
NCT07147231Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
National Cancer Institute (NCI)
PHASE1|PHASE2
RECRUITING
NCT07148128Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Auricula Biosciences Inc.
PHASE1|PHASE2
RECRUITING
NCT07153614Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy
University of Tennessee Graduate School of Medicine
NA
RECRUITING
NCT07158164DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
PHASE4
RECRUITING
NCT07161713SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
Barbara Nemesure
NA
RECRUITING
NCT07162337BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
Massachusetts General Hospital
NA
RECRUITING
NCT07167446Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Fox Chase Cancer Center
EARLY_PHASE1
RECRUITING
NCT07169734A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Alentis Therapeutics AG
PHASE1|PHASE2
RECRUITING
NCT07172282INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
Northwell Health
EARLY_PHASE1
RECRUITING
NCT07173985Strategies for Optimizing a Mailed FIT Program in Appalachia
Ohio State University Comprehensive Cancer Center
NA
RECRUITING
NCT07183046Implementation Intention Planning Guide for FIT Colon Cancer Screening
Dartmouth-Hitchcock Medical Center
NA
NOT_YET_RECRUITING
NCT07186842A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
BioNTech SE
PHASE1|PHASE2
RECRUITING
NCT07189871177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
PHASE1|PHASE2
RECRUITING
NCT07193862Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
Northwell Health
EARLY_PHASE1
RECRUITING
NCT07198945Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection
Indiana University
NA
ENROLLING_BY_INVITATION
NCT07201519Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Michael J Cavnar, MD
PHASE2
RECRUITING
NCT07209215ctDNA-Informed Management of Early-Stage Rectal Cancer
University of California, Davis
PHASE2
NOT_YET_RECRUITING
NCT07213609A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
GlaxoSmithKline
PHASE1|PHASE2
RECRUITING
NCT07213791A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Eli Lilly and Company
PHASE1
RECRUITING
NCT07215000Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
Morehouse School of Medicine
PHASE4
RECRUITING
NCT07216105FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Fate Therapeutics
PHASE1
RECRUITING
NCT07216560First-in-human Study of 7MW4911 in GI Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
PHASE1|PHASE2
RECRUITING
NCT07219238Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
GE Healthcare
PHASE2|PHASE3
RECRUITING
NCT07219537A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
Massachusetts General Hospital
NA
RECRUITING
NCT07219745Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)
Case Comprehensive Cancer Center
NA
NOT_YET_RECRUITING
NCT07220018Colorectal Cancer Screening in the Homeless
George Washington University
NA
RECRUITING
NCT07220239Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
Jessica D. St. Laurent, MD
NA
RECRUITING
NCT07221058Adaptive Radiation Boost for Rectal Cancer
Fox Chase Cancer Center
PHASE1
RECRUITING
NCT07221357A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb
PHASE2|PHASE3
RECRUITING
NCT07222800Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
PHASE3
RECRUITING
NCT07223047A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Bristol-Myers Squibb
PHASE1|PHASE2
RECRUITING
NCT07223424Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Diwakar Davar
PHASE2
RECRUITING
NCT07224464The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
New Phase Ltd.
NA
RECRUITING
NCT07225309A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
NA
RECRUITING
NCT07227077Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Medical College of Wisconsin
NA
RECRUITING
NCT07227168A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Sutro Biopharma, Inc.
PHASE1
RECRUITING
NCT07227636A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
Memorial Sloan Kettering Cancer Center
PHASE2
RECRUITING
NCT07228000Bundled Cancer Screening and Genetic Services Navigation
Georgetown University
NA
RECRUITING
NCT07228832Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Summit Therapeutics
PHASE3
RECRUITING
NCT07229313A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
PHASE1
RECRUITING
NCT07230795AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake
Abramson Cancer Center at Penn Medicine
NA
ENROLLING_BY_INVITATION
NCT07234968Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Thomas Jefferson University
NA
RECRUITING
NCT07235293A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Kahr Bio Australia Pty Ltd
PHASE2
RECRUITING
NCT07254910Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
University of Oklahoma
NA
RECRUITING
NCT07262619EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Eikon Therapeutics
PHASE1|PHASE2
RECRUITING
NCT07271355Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
City of Hope Medical Center
PHASE3
RECRUITING
NCT07276529Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
GI Windows, Inc.
NA
RECRUITING
NCT07277270A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
GlaxoSmithKline
PHASE1
RECRUITING
NCT07277322Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Dan Feng
PHASE1|PHASE2
RECRUITING
NCT07281716Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC
Dan Feng
PHASE1|PHASE2
RECRUITING
NCT07281768Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
PHASE2
RECRUITING
NCT07283939Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Alliance for Clinical Trials in Oncology
NA
RECRUITING
NCT07284849A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
PHASE3
RECRUITING
NCT07285044The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mayo Clinic
PHASE2
RECRUITING
NCT07290309Survivors Uniting for Remote Guided Exercise
Colorado State University
NA
RECRUITING
NCT07291180A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis
Yale University
NA
RECRUITING
NCT07291414A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
University of Michigan Rogel Cancer Center
NA
RECRUITING
NCT07292298Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
University of Colorado, Denver
PHASE2
RECRUITING
NCT07296887CARE Tool Study Aim 3
Washington University School of Medicine
NA
RECRUITING
NCT07300150A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
PAQ Therapeutics, Inc.
PHASE1
RECRUITING
NCT07304063Overcoming Barriers to Uptake of Cascade Screening
UNC Lineberger Comprehensive Cancer Center
NA
NOT_YET_RECRUITING
NCT07307664Increasing Germline Genetic Testing for Patients With Cancer
Josh Peterson
NA
RECRUITING
NCT07317505A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
PHASE1
RECRUITING
NCT07318389ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
EARLY_PHASE1
RECRUITING
NCT07318805A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Pfizer
PHASE1
RECRUITING
NCT07321106A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Cartography Biosciences
PHASE1
RECRUITING
NCT07337525A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Pilatus Biosciences Inc
PHASE1
RECRUITING
NCT07337590Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Exero Medical Ltd.
NA
RECRUITING
NCT07345676Colorectal Cancer Screening Outreach
Yale University
NA
RECRUITING
NCT07349537Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Revolution Medicines, Inc.
PHASE1
RECRUITING
NCT07351071Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
Medtronic - MITG
NA
RECRUITING
NCT07361107Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)
Northwell Health
PHASE1
RECRUITING
NCT07361614Pilot Testing of a Colorectal Cancer Education Program
NYU Langone Health
NA
RECRUITING
NCT07363408Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
City of Hope Medical Center
PHASE1
NOT_YET_RECRUITING
NCT07381985Strategy for Management of Patients With Hereditary Cancer Syndromes (HCS) in a Rural Environment
University of Vermont Medical Center
NA
ENROLLING_BY_INVITATION
NCT07391956Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
Icahn School of Medicine at Mount Sinai
NA
RECRUITING
NCT07393906Colorectal Cancer Prevention Research Study: Eat Right, Screen Right
University of Florida
NA
RECRUITING
NCT07397338Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Revolution Medicines, Inc.
PHASE1|PHASE2
RECRUITING
NCT07398456Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas
Baylor Research Institute
NA
NOT_YET_RECRUITING
NCT07403981Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
Stanford University
NA
RECRUITING
NCT07405476Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
PHASE2
RECRUITING
NCT07406087Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
NA
RECRUITING
NCT07407647Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
PHASE2
RECRUITING
NCT07408258Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
OncoC4, Inc.
PHASE1
RECRUITING
NCT07411599Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
M.D. Anderson Cancer Center
PHASE1|PHASE2
RECRUITING
NCT07415031A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Mirati Therapeutics Inc.
PHASE2
RECRUITING
NCT07416552A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
Hoffmann-La Roche
PHASE1
RECRUITING
NCT07417488GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
Thomas Jefferson University
PHASE1
RECRUITING
NCT07419490Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
University of South Florida
NA
RECRUITING
NCT07425054ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
Jennifer Dorth
PHASE2
RECRUITING
NCT07429110ColoSeal™ ICD System Anastomotic Protection Pivotal Study
Averto Medical, Inc.
NA
ACTIVE_NOT_RECRUITING
NCT07432633[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Blue Earth Diagnostics
PHASE1|PHASE2
RECRUITING
NCT07433673Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
Columbia University
PHASE2
RECRUITING
NCT07436078Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
Barbara Ann Karmanos Cancer Institute
NA
RECRUITING
NCT07436637Guardant Shield Colorectal Cancer Screening
University of Miami
NA
RECRUITING
NCT07436728A Study of TAK-505 in Adults With Solid Tumors
Takeda
PHASE1|PHASE2
RECRUITING
NCT07446322FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Oncolytics Biotech
PHASE2
RECRUITING
NCT07447050Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
PHASE2
RECRUITING
NCT07454642AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Avacta Life Sciences Ltd
PHASE1
RECRUITING
NCT07458347A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
PHASE1
RECRUITING
NCT07463599Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
HonorHealth Research Institute
PHASE1|PHASE2
RECRUITING
NCT07464236Improving Clinic Delivery of HIV-related Anal Health Services
Albert Einstein College of Medicine
NA
NOT_YET_RECRUITING
NCT07487168Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
PHASE1
RECRUITING
NCT07488676A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Astellas Pharma Global Development, Inc.
PHASE1|PHASE2
RECRUITING
NCT07500298Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
PHASE1
RECRUITING
NCT07503808A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
IDEAYA Biosciences
PHASE1
RECRUITING
NCT07511023Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum
M.D. Anderson Cancer Center
PHASE2
NOT_YET_RECRUITING
NCT07522177Animated Storytelling to Promote Colorectal Cancer Screening
Stanford University
NA
NOT_YET_RECRUITING
NCT07525206A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
AbbVie
PHASE3
RECRUITING
NCT07527858Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
Gilead Sciences
PHASE2
RECRUITING
NCT07528963KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice
University of Kansas Medical Center
NA
ENROLLING_BY_INVITATION
NCT07529808Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
BigHat Biosciences, Inc.
PHASE1|PHASE2
RECRUITING
NCT07535112A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
Bayer
PHASE1
RECRUITING
NCT07540572A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
IDEAYA Biosciences
PHASE1
RECRUITING
NCT07542405A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families
University of Michigan Rogel Cancer Center
NA
NOT_YET_RECRUITING
NCT07544589A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Dispatch Biotherapeutics
PHASE1
RECRUITING
NCT07549412A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
EMD Serono Research & Development Institute, Inc.
PHASE3
RECRUITING
NCT07550088BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
Darren Sigal, MD
PHASE2
RECRUITING
NCT07551596Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
National Cancer Institute (NCI)
PHASE2
RECRUITING
NCT07553572Remote Monitoring and Symptom Management Digital Application
Patrick C. Johnson, MD
NA
RECRUITING
NCT07555210Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
Jessica Mezzanotte Sharpe
NA
RECRUITING
NCT07567027Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
NYU Langone Health
NA
RECRUITING
NCT07569250Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
University of Colorado, Denver
NA
NOT_YET_RECRUITING
NCT07578571A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Immunome, Inc.
PHASE1
RECRUITING
NCT07580339Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
PHASE2
NOT_YET_RECRUITING
NCT07582003S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas
Jun Gong, MD
PHASE1
NOT_YET_RECRUITING
NCT07592793Community Gateway to Health Study
Harvard School of Public Health (HSPH)
NA
ENROLLING_BY_INVITATION
NCT07594067TCR1188-ABC Cells in KRAS-mutated Cancers
University of Pennsylvania
PHASE1
RECRUITING
NCT07594626BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Northwestern University
PHASE1|PHASE2
RECRUITING
NCT07595874Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
City of Hope Medical Center
PHASE2
RECRUITING
NCT07612007HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
Mayo Clinic
PHASE2
NOT_YET_RECRUITING
NCT07618273Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial
Mayo Clinic
NA
RECRUITING
NCT07620574Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
Exelixis
PHASE3
ENROLLING_BY_INVITATION
NCT07627191GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
University of Arizona
EARLY_PHASE1
RECRUITING
NCT07629960A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Blueprint Medicines Corporation
PHASE1|PHASE2
RECRUITING
NCT07636785A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
VM Discovery, Inc.
PHASE1|PHASE2
RECRUITING
NCT07638410Prehabilitation in High-risk Oncologic Surgery
Fox Chase Cancer Center
NA
RECRUITING
NCT07650357A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
Clasp Therapeutics, Inc.
PHASE1
NOT_YET_RECRUITING
NCT07658196TLR9 Immunotherapy for Peritoneal Carcinomatosis
Brown University
PHASE1
RECRUITING
NCT07659795A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Verastem, Inc.
PHASE2
RECRUITING
NCT07662031Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
Washington University School of Medicine
PHASE2
NOT_YET_RECRUITING
NCT07691489A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
Memorial Sloan Kettering Cancer Center
PHASE2
NOT_YET_RECRUITING
NCT07693751A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
SOTIO Biotech a.s.
PHASE1|PHASE2
RECRUITING
NCT07701707Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer Survivors
Massachusetts General Hospital
NA
NOT_YET_RECRUITING
NCT07702032Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Genmab
PHASE3
RECRUITING
NCT07705334A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
SHY Therapeutics
PHASE1
RECRUITING
NCT07715903Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
National Cancer Institute (NCI)
PHASE1
NOT_YET_RECRUITING
NCT07735624RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
Dana-Farber Cancer Institute
PHASE2
RECRUITING
NCT07738939IKS04 Regimen in Advanced Solid Tumors That Express CA242
Iksuda Therapeutics Ltd.
PHASE1
NOT_YET_RECRUITING
NCT07743723A Study of IOV-5001 in Adults With Advanced Solid Tumors
Iovance Biotherapeutics, Inc.
PHASE1|PHASE2
NOT_YET_RECRUITING
NCT07748377Increasing Breast and Colorectal Cancer Screening in the Community
Icahn School of Medicine at Mount Sinai
NA
NOT_YET_RECRUITING
NCT07749586A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Arvinas Inc.
PHASE1|PHASE2
RECRUITING
NCT07750158Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Exelixis
PHASE3
RECRUITING
NCT07759921Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
University of Colorado, Denver
NA
RECRUITING
NCT07781774Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach
Washington University School of Medicine
NA
NOT_YET_RECRUITING
NCT07781852Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
Lumina Pharmaceuticals Inc
EARLY_PHASE1
NOT_YET_RECRUITING
NCT07790718Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
City of Hope Medical Center
NA
RECRUITING
NCT07795749Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
University of California, Irvine
PHASE2
RECRUITING
NCT07795801Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors
Massachusetts General Hospital
NA
NOT_YET_RECRUITING
NCT07796334Colon Health Champion Program
Virginia Commonwealth University
NA
NOT_YET_RECRUITING
NCT07796763A Global Trial of Trastuzumab Rezetecan (SHR-A1811) in Combination With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Colorectal Cancer Expressing HER2
Jiangsu HengRui Medicine Co., Ltd.
PHASE2
NOT_YET_RECRUITING
NCT07807345Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
Sutro Biopharma, Inc.
PHASE1
NOT_YET_RECRUITING
NCT07808151Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Solstice Oncology, Inc.
PHASE2
RECRUITING
NCT07811193A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Vividion Therapeutics, Inc.
PHASE2
RECRUITING
NCT07812805SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
SK Life Science, Inc.
PHASE1
RECRUITING
NCT07842965CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
City of Hope Medical Center
PHASE1
NOT_YET_RECRUITING